title: Modifications of microfilaments and microtubules induced by two hepatic tumor promoters, phenobarbital and biliverdin in non-transformed and transformed hepatic cell lines.
abstract: Microfilaments and microtubules are components of the cytoskeleton which could be implicated in neoplastic transformation. We studied the effect of two hepatic tumor promoters, phenobarbital (PB) and biliverdin (BV), on microfilaments and microtubules of non-transformed (Cl3) and transformed (FV) hepatic epithelial cells. Cl3 non-transformed cells cultured in the presence of 1 X 10(-6) M BV for 48 h showed a loss of F-actin, fragmentation of actin and the appearance of star-like structures in the cytoplasm, as well as loosening of the peripheral bundle of actin, and some ruffling of cell membranes. In Cl3 cells exposed to 0.2 X 10(-3) M PB a similar disappearance of F-actin staining and a very prominent ruffling of cell membrane were observed. BV and PB also produced in these cells modifications of microtubules characterized by a disappearance of centrosome staining in numerous cells, a condensed ring of tubulin around the nucleus and a depolymerized aspect of the microtubular network. All these modifications of microfilaments and microtubules closely resembled those observed in FV transformed cells in the absence of any treatment (Solvent DMSO only). We did not observe an effect of BV and PB on FV cells. The present data demonstrate that the cytoskeleton of non-transformed epithelial liver cells is sensitive to the action of liver tumor promoters suggesting that it might play a role as to yet be defined in the promotion mechanism.
authors.affiliation: Institut de Recherches Scientifiques sur le Cancer CNRS, Villejuif, France.
authors.forename: F
authors.initials: F
authors.lastname: Decloitre
authors.forename: C
authors.initials: C
authors.lastname: Lafarge-Frayssinet
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: C
authors.initials: C
authors.lastname: Frayssinet
mesh_terms: D008841:Actin Cytoskeleton / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D000199:Actins / Q000378:metabolism; D000818:Animals; D001663:Bilirubin / Q000031:analogs & derivatives*; D001664:Biliverdine / Q000494:pharmacology*; D002460:Cell Line; D002461:Cell Line, Transformed; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D003599:Cytoskeleton / Q000187:drug effects*; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D008099:Liver / Q000166:cytology* / Q000187:drug effects / Q000648:ultrastructure; D008870:Microtubules / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D010634:Phenobarbital / Q000494:pharmacology*; D010641:Phenotype; D051381:Rats; D012235:Rhodamines; D014404:Tubulin / Q000378:metabolism; D005723:gamma-Glutamyltransferase / Q000378:metabolism
chemical_list: D000199:Actins; D012235:Rhodamines; D014404:Tubulin; D005723:gamma-Glutamyltransferase; D001664:Biliverdine; D001663:Bilirubin; D004121:Dimethyl Sulfoxide; D010634:Phenobarbital